Menu

Global Vocal Biomarkers Market Size, By Indication (psychiatric disorders (depression, attention deficit and disruptive behavior disorders, others), neurological disorders (Parkinson’s disease (PD), Alzheimer's disease, Huntington's disease), respiratory disorders, cardiovascular disorders, traumatic brain injury (TBI)) and others), Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific -India, Japan, China, Australia, Other) (Europe - UK, Russia, France, Brazil, Other) (Middle East and Africa) - Global Industry Insights, Trends and Forecast, 2017-2025

Report Format : PDF
Published Date : Oct-2018
Pages : 160
Report ID : VSR00254

Global Vocal Biomarkers Market Size showed crucial growth in the recent years and is anticipated to witness a steep rise by generating an estimated revenue of US$ xx.xx over the forecast period. According to latest study conducted by our analysts and industry experts, the global market is expected to grow at a CAGR of 13.9% during the forecast period, i.e. 2017-2025. Vocal biomarkers have amazing potential in reforming diagnostics through their accuracy, speed and cost-effectiveness in the areas of mental illnesses as well as physical diseases such as Parkinson’s or coronary artery disease. Vocal biomarkers have an amazing potential in reforming diagnostics through their accuracy, speed and cost-effectiveness.

Global Vocal Biomarkers Market Growth Opportunities (Revenue, Growth) By 2017-2025

Global Vocal Biomarkers Market Share

This global market study report analysis offers in-depth insights, revenue details, and other vital information regarding the global vocal biomarkers market, and the various trends, drivers, restraints, opportunities, and threats in the target market till 2025. The report offers insightful and detailed information regarding the various key players operating in the market, their financials, supply chain trends, technological innovations, key developments, apart from future strategies, acquisitions & mergers, and market footprint. The global vocal biomarkers market report has been segmented on the basis of type, application, and region. It includes the estimation of the market size, in terms of value, with respect to 4 main geographies, namely, North America, Europe, APAC, and RoW.   

Market Dynamics

Vocal Biomarkers market is estimated to grow at a CAGR of 13.9% from 2017-2025. The market growth is basically driven by the increasing number of geriatric population, and rising number of cardiovascular incidences, psychological, neurological and other diseases affecting speech such as depression, Attention Deficit and Disruptive Behavior Disorders, Parkinson's disease (PD), Alzheimer's disease, Huntington's disease, Respiratory and Cardiovascular Disorders, traumatic brain injury (TBI) etc.

Furthermore, upward trend for the use non-invasive vocal biomarkers for diagnosis of various psychological disorders to boost the market growth during the forecast period. Unlike other conventional and minimally invasive technologies such as ECG and MRI, which are impracticable for remote health monitoring on account of their high costs, vocal biomarkers serve as non-invasive diagnostic tools that provide great ease to patients with psychiatric disorders.

Segment Analysis 

Based on the indication type, the Vocal Biomarkers market is segmented as psychiatric disorders (depression, attention deficit and disruptive behavior disorders, others), neurological disorders (Parkinson’s disease (PD), Alzheimer's disease, Huntington's disease, others), respiratory disorders, cardiovascular disorders, traumatic brain injury (TBI), others) and others.  Psychiatric disorders to be the dominating segment owning to the rising prevalence of Alzheimer’s disease in the elderly population. According to the Alzheimer’s Association Alzheimer is the sixth leading cause of death in the United States. 

Regional Analysis

North America to hold the largest market share in this industry, the U.S. is the most important sector and captured a majority share of the North American segment. Robust healthcare infrastructure and presence of well-funded research organizations equipped with cutting-edge technologies in North America have made the region a lucrative breeding place for vocal biomarkers. Tie-ups of the U.S. government agencies with voice-based companies and analysis researchers is a primary demand determinant for vocal biomarkers in the region across areas such as geriatrics and war-induced trauma to also support the market growth during the forecast period.

Global Vocal Biomarkers Market Size, Share Analysis By Region 2017

Global Vocal Biomarkers Market Size

Key Players

Major players operating in global Vocal Biomarkers market include Beyond Verbal, Sonde Health, Audio Profiling, IBM Corporation, Cogito Corporation and others.

Global Vocal Biomarkers Market Study Report Offer You!

The global market study report gives an idea about market size, share, stock, equity, investment and total price analysis. Also, the report provides comprehensively industry insights with all major factors such as market credit, allocation, demand, distribution, market scope, key players, end user & applications, provisions, livestock, commodities and industry economics analysis, future growth & forecast. The global market report includes all depth data like pre-market emphasis, market survey, market investment, industry advice, portfolio, finance, access, trade, market exploration, industry review and market predication & projection to develop effective strategies for optimizing their market position.

Enquiry for Table of Content

Global Vocal Biomarkers Market Size, By Indication (psychiatric disorders (depression, attention deficit and disruptive behavior disorders, others), neurological disorders (Parkinson’s disease (PD), Alzheimer's disease, Huntington's disease), respiratory disorders, cardiovascular disorders, traumatic brain injury (TBI)) and others), Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific -India, Japan, China, Australia, Other) (Europe - UK, Russia, France, Brazil, Other) (Middle East and Africa) - Global Industry Insights, Trends and Forecast, 2017-2025

Enquiry for Methodology

Global Vocal Biomarkers Market Size, By Indication (psychiatric disorders (depression, attention deficit and disruptive behavior disorders, others), neurological disorders (Parkinson’s disease (PD), Alzheimer's disease, Huntington's disease), respiratory disorders, cardiovascular disorders, traumatic brain injury (TBI)) and others), Regional Analysis (North America - U.S, Canada, Other) (Asia-Pacific -India, Japan, China, Australia, Other) (Europe - UK, Russia, France, Brazil, Other) (Middle East and Africa) - Global Industry Insights, Trends and Forecast, 2017-2025

Single User: $4,999
Multi User: $6,999
Enterprice Licence: $8,999

Get 15% Discount

Why Choose Veracious Statistics Research ?

Save Your Time

Cost-Effective Services

Wide Range of Reports

World Class Market Research

100% Customer Satisfaction

24/7 Customer care Support

Any more questions?

Get in touch with us quickly and easily. We are happy to help!

Contact us

Sales Shaulova

Global Operations Manager +1-937-947-0908 Mon - Fri - 24/7/

Let's Talk Online